根据该协议,Karveer有权在印度将公司的COVID药物NV-CoV-2和NV-CoV-2-R商业化。为了实现商业化,Karveer已经进行了临床开发和评估,并为此在印度赞助了这两种药物。
蹊之美股生物医药2021-09-23 23:00
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aethlon Medical (NASDAQ:AEMD) +33%
Onconova Therapeutics (NASDAQ:ONTX) +28%
Dynavax Technologies (NASDAQ:DVAX) +26%
Candel Therapeutics (NASDAQ:CADL) +18%
BioCardia ...查看全文
蹊之美股生物医药2021-07-29 21:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI) +62%
Tilray (NASDAQ:TLRY) +25%
Grove (NASDAQ:GRVI)+20%
NeuroMetrix (NASDAQ:NURO) +2%
成纤维细胞生长因子3是一种在多种肿瘤类型,尤...查看全文
智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NanoViricides(NNVC)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-20-114577 Act: 34 Size: 9 MB 网页链接
$NanoViricides(NNVC)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001104659-20-109325 Act: 34 Size: 22 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-20-102620 Act: 34 Size: 38 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-20-089704 Act: 34 Size: 282 KB 网页链接
$NanoViricides(NNVC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-089188 Act: 33 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001387131-20-006537 Act: 34 Size: 128 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-20-083121 Act: 34 Size: 354 KB 网页链接
$NanoViricides(NNVC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-082422 Act: 33 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-082204 Act: 33 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-20-075651 Act: 34 Size: 5 MB 网页链接